Role of Vitamin D in Reducing the Frequency of Asthma Attacks in Patients with Frequent Exacerbation of Asthma
Mubeen Ahmed Memon
Department of Pulmonology, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan.
Sheeba Faryal Ansari
Department of Medicine, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan.
Mumtaz Ali Lakho
Department of Medicine, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan.
Mukhtiar Hussain Jaffery
Department of Medicine, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan.
Syed Zulfiquar Ali Shah *
Department of Medicine, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan.
Samar Raza
Department of Medicine, Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Vitamin D deficiency is common among asthmatics with literature suggesting that its low levels in the body may trigger exacerbations and decrease the response to corticosteroid treatment. It has also shown to inhibit the production of cytokines, which in turn enhances the body’s response to corticosteroid treatment during an exacerbation. Therefore, maintenance of adequate levels of vitamin D in patients with asthma may reduce the risk of exacerbation and improve their general health. This study aims to explore the role of vitamin D supplementation in preventing asthma exacerbations.
Methods: This single blind parallel arm interventional study was conducted in the pulmonology ward in a tertiary care hospital from June 2018 to April 2020. Two hundred (n= 200) participants with a history of frequent acute exacerbation of asthma were enrolled in the study via consecutive convenient non-probability technique. Participants were divided into two groups; the placebo and the interventional group that received 200,000 IU of vitamin D capsule.
Results: Compared to day 0, mean episodes of exacerbation in the interventional group were significantly lower after 180 days (1.1 ± 0.4 vs. 0.61 ± 0.3; p-value <0.0001). Similarly, number of asthma attacks in past 7 days was significantly lower in intervention group after 180 days (4.4
± 2.7 vs. 3.1 ± 1.5; p-value 0.0001)
Conclusion: Vitamin D supplementation is a safe and cost-friendly approach to reducing asthma exacerbations. It may also help to improve the condition in severe asthmatics with low vitamin D levels.
Keywords: Vitamin D, asthma, obstructive lung disease, bronchial asthma and acute exacerbation of asthma